HCN2
hyperpolarization activated cyclic nucleotide-gated potassium channel 2
HCN2; hyperpolarization activated cyclic nucleotide-gated potassium channel 2; potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2;
HCN3
hyperpolarization-activated cyclic nucleotide-gated potassium channel 3
HCN3; hyperpolarization-activated cyclic nucleotide-gated potassium channel 3; potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3;
HCN4
hyperpolarization activated cyclic nucleotide-gated potassium channel 4
HCN4; hyperpolarization activated cyclic nucleotide-gated potassium channel 4; potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4; hyperpolarization activated cyclic nucleotide-gated cation channel 4; SSS2;
HCN1
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
HCN1; hyperpolarization-activated cyclic nucleotide-gated potassium channel 1; potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1;
PERP
PERP, TP53 apoptosis effector
PERP; PERP, TP53 apoptosis effector; p53 apoptosis effector related to PMP-22; dJ496H19.1; KCP1; KRTCAP1; PIGPC1; THW; KCP-1; 1110017A08Rik; transmembrane protein THW; p53-induced protein PIGPC1; keratinocyte-associated protein 1; keratinocytes associated;